Plan, design, and implement A/B tests and experiments with statistical rigor. Covers hypothesis frameworks, sample sizing, metrics, and result analysis.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
FDA regulatory consulting — 510(k)/PMA/De Novo pathway guidance, QSR (21 CFR 820) compliance, HIPAA assessments, and device cybersecurity.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
실행 점수 미검증
설치 방법 보기설치하기 전에 에이전트에게 전달되는 지시 내용을 확인할 수 있습니다.
FDA regulatory consulting for medical device manufacturers covering submission pathways, QSR, HIPAA, and device cybersecurity.
Predicate device exists?
├── YES → Substantially equivalent?
│ ├── YES → 510(k) (Traditional / Special / Abbreviated)
│ └── NO → PMA or De Novo
└── NO → Novel device?
├── Low-to-moderate risk → De Novo
└── High risk (Class III) → PMA
| Pathway | When to Use | Timeline | Cost |
|---|---|---|---|
| 510(k) Traditional | Predicate exists, design changes | 90 days | $21,760 |
| De Novo | Novel, low-moderate risk | 150 days | $134,676 |
| PMA | Class III, no predicate | 180+ days | $425,000+ |
For pathway decision matrices and Pre-Submission strategy, see references/fda_submission_guide.md.
For required sections (21 CFR 807.87) and common RTA issues, see references/fda_submission_guide.md.
| Section | Title | Focus |
|---|---|---|
| 820.20 | Management Responsibility | Quality policy, management review |
| 820.30 | Design Controls | Input, output, V&V, transfer |
| 820.40 | Document Controls | Approval, distribution, changes |
| 820.100 | CAPA | Root cause, corrective actions |
For design controls workflow and CAPA process details, see references/qsr_compliance_requirements.md.
Applies to devices that create, store, transmit, or access PHI. Requires:
For applicability matrix, safeguard details, and risk assessment steps, see references/hipaa_compliance_framework.md.
| Element | Description |
|---|---|
| Threat Model | STRIDE analysis, attack trees, trust boundaries |
| Security Controls | Authentication, encryption, access control |
| SBOM | Software Bill of Materials (CycloneDX or SPDX) |
| Security Testing | Penetration testing, vulnerability scanning |
For device tier classification, postmarket obligations, and vulnerability disclosure process, see references/device_cybersecurity_guidance.md.
| Script | Purpose |
|---|---|
fda_submission_tracker.py | Track submission milestones and timelines |
qsr_compliance_checker.py | Assess 21 CFR 820 compliance |
hipaa_risk_assessment.py | Evaluate HIPAA safeguards |
| Document | Content |
|---|---|
| fda_submission_guide.md | Submission requirements and checklists |
| qsr_compliance_requirements.md | 21 CFR 820 implementation guide |
| hipaa_compliance_framework.md | HIPAA Security Rule and BAA requirements |
| device_cybersecurity_guidance.md | FDA cybersecurity, SBOM, threat modeling |
| fda_capa_requirements.md | CAPA process and root cause analysis |
아직 리뷰가 없습니다. 사용해 본 소감을 남겨 주세요.
로그인 없이 쓸 수 있습니다. 사용 후기, 질문, 작동하지 않은 환경 등을 편하게 남겨 주세요.
아직 댓글이 없습니다. 첫 댓글을 남겨 보세요.
Plan, design, and implement A/B tests and experiments with statistical rigor. Covers hypothesis frameworks, sample sizing, metrics, and result analysis.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Web/mobile accessibility decision guide: WCAG 2.2 AA, ARIA, keyboard nav, focus management, contrast, testing. Use for: a11y, accessibility, wcag, aria, screen reader, keyboard, contrast.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Generate, iterate, and scale ad creative for paid advertising across Google, Meta, LinkedIn, and X. Covers platform specs, creative frameworks, and quality validation.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Musica interactiva para juegos: layering vertical, re-secuenciacion horizontal, stingers, reglas de transicion con sync points, y mapeo de estados de gameplay a musica. Usar para: musica adaptativa, sistema de musica dinamica, transiciones musicales, combat music.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Design multi-agent systems, create agent architectures, define communication patterns, and build autonomous agent workflows with structured evaluation frameworks.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Inter-agent communication protocol for C-suite agent teams. Defines invocation syntax, loop prevention, isolation rules, response formats, and quality loops.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.